However, USADA writes it is important to realize that these are unproven claims, and that the use of BPC-157 for these or any other reasons is not supported by medical literature or by any medical associations. So for all these reasons, I currently do NOT recommend BPC 157
While results are promising, extrapolating dosage and safety to humans remains speculative
Three timing windows
18 While there are now a number of new treatments, the German PsoBest registry still shows that approximately half of those who receive non-biological therapy receive a FAE, with currently many being switched to DMF alone
Clinical RCT 2014 Phase 2b RCT in postoperative ileus (bowel resection inpatients) Beck, Sweeney, and McCarter (Ipamorelin 201 Study Group) reported a multicenter, double-blind, placebo-controlled proof-of-concept study in bowel-resection inpatients